Roles of γ-aminobutyric acid(B) (GABA(B)) and γ-hydroxybutyric acid receptors in hippocampal long-term potentiation and pathogenesis of absence seizures

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 10, 1997, Pages 1066-1070

  Aizawa, Masahiro ^a   Ito, Yoshihisa ^a   Fukuda, Hideomi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Absence seizure; Long term potentiation; aminobutyric acid(B) (GABA(B)) receptor; hydroxybutyric acid (GHB) receptor

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 HYDROXYBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID RECEPTOR; 4 HYDROXYBUTYRIC ACID RECEPTOR BLOCKING AGENT; BACLOFEN; GAMMA BUTYROLACTONE; NCS 382; PRODRUG; UNCLASSIFIED DRUG;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOUSE; NONHUMAN; SPIKE WAVE; THALAMOCORTICAL TRACT;

EID: 0030716220     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.1066     Document Type: Article

References (40)

1. Roth R. H., Giarman N. J., Biochem. Pharmacol., 15, 1333-1348 (1966).
2. Hechler V., Gobaille S., Maitre M., Brain Res., 572, 345-348 (1992).
3. Ito Y., Ishige K., Zaitsu E., Anzai K., Fukuda H., J. Neurochem., 65, 75-83 (1995).
4. Mathivet P., Bernasconi R., de Barry J., Marescaux C., Bittiger H., Eur. J Pharmacol., 321, 67-75 (1997).
5. Williams D., Brain, 76, 50-69 (1953).
6. Coulter D. A., Huguenard J. R., Prince D. A., Ann. Neurol., 25, 582-593 (1989).
7. Snead O. C., Neurology, 28, 643-648 (1978).
8. Snead O. C., J. Neural Transm., 35, 7-19 (1992).
9. Aizawa M., Ishige K., Ito Y., Fukuda H., "GABA: Receptors, Transporters and Metabolism," ed. by Tanaka C., Bowery N.G., Birkhaüser, Basel, 1996, pp. 321-324.
10. Snead O. C., Eur. J. Pharmacol. 213, 343-349 (1992).
11. Hosford D. A., Wang Y., Liu C.-C., Snead O. C., J. Pharmacol. Exp. Ther., 274, 1399-1403 (1995).
12. Marescaux C., Liu Z., Bernasconi R., Vergnes M., Pharmacol. Commun., 2, 57-62 (1992).
13. Snead O. C., Ann. Neurol., 37, 146-157 (1995).
14. Sandyk R., Gillman M. A., Clin. Neuropharmacol., 8, 294-295 (1985).
15. DeSousa N. J., Beninger R. J., Jhamandas K., Boegman R., Brain Res., 641, 29-38 (1994).
16. McNamara R. K., Skelton R. W., Brain Res. Rev., 18, 33-49 (1993).
17. Nakagawa Y., Ishibashi Y., Yoshii T., Tagashira E., Brain Res., 683, 209-214 (1995).
18. Stackman R. W., Walsh T. J., Behav. Neural Biol. 61, 181-185 (1994).
19. Swartzwelder H. S., Tilson H. A., McLamb R. L., Wilson W. A., Psychopharmacology, 92, 398-401 (1987).
20. Bliss T. V. P., Collingridge G. L., Nature (London), 361, 31-39 (1993).
21. Davies C. H., Starkey S. J., Pozza M. F., Collingridge G. L., Nature (London), 349, 609-611 (1991).
22. Mott D. D., Lewis D. V., Science, 252, 1718-1720 (1991).
23. Olpe H.-R., Karlsson G., Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 194-197 (1990).
24. Xie X., Smart T. G., Eur. J. Pharmacol., 212, 291-294 (1992).
25. Ishida N., Kasamo K., Nakamoto Y., Suzuki J., Brain Res., 608, 52-57 (1993).
26. Ishige K., Aizawa M., Ito Y., Fukuda H., Neuropharmacology, 35, 45-55 (1996).
27. Haung Y.-Y., Li X.-C., Kandel E. R., Neuron, 79, 69-79 (1994).
28. Hechler V., Ratomponirina C., Maitre M., J. Pharmacol. Exp. Ther., 281, 753-760 (1997).
29. Snead O. C., Neuropharmacology, 30, 161-167 (1991).
30. Emri Z., Turner J. P., Crunelli V., Neuroscience, 72, 689-698 (1996).
31. Emri Z., Antal K., Crunelli V., Neurosci. Lett., 216, 121-124 (1996).
32. Snead O. C., Abstracts of Papers, The 26th Annual Meeting of Society for Neuroscience, Washington, November 1996, p. 2095.
33. Hosford D. A., Clark S., Cao Z., Wilson W. A., Lin F.-H., Morrisett R. A., Huin A., Science, 257, 398-401 (1992).
34. Lin F.-H., Cao Z., Hosford D. A., Brain Res., 608, 101-106 (1993).
35. Caddick S. J., Hosford D. A., Neurosci. Lett., 205, 29-32 (1996).
36. Caddick S. J., Hosford D. A., Abstracts of Papers, The 26th Annual Meeting of Society for Neuroscience, Washington, November 1996, p. 2099.
37. Aizawa M., Ito Y., Fukuda H., Neurosci. Res., 29, 17-25 (1997).
38. Maitre M., Hechler V., Vayer P., Gobaille S., Cash C. D., Schmitt M., Bourguignon J. J., J. Pharmacol. Exp. Ther., 255, 657-663 (1990).
39. Aizawa M., Ishige K., Ito Y., Fukuda H., Abstracts of Papers, The 117th Annual Meeting of Pharmaceutical Society of Japan, Tokyo, March 1997, Part 3, p. 17.
40. Banerjee P. K., Snead O. C., J. Pharmacol. Exp. Ther., 273, 1534-1543 (1995).